Sun Pharmaceuticals Deal History & Licensing Activity
Sun Pharmaceuticals is a life sciences. Over the past three years, Sun Pharmaceuticals has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals). The company currently has 5 active clinical trials, primarily in Solid Tumors.
Deals (12mo)
1
Active Trials
5
Top Modality
Other
Focus Area
Solid Tumors
Sun Pharmaceuticals Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Sun Pharmaceuticals in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Organon (company acquisition) | Organon | Other | Approved | acquisition | Apr 2026 |
Sun Pharmaceuticals Pipeline Focus
Therapeutic areas and modalities where Sun Pharmaceuticals is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Sun Pharmaceuticals Clinical Pipeline
Sun Pharmaceuticals has 5 active clinical trials across 2 development phases.
1
Phase 2
4
Phase 3
See How Your Asset Matches Sun Pharmaceuticals's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Solid Tumors assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Sun Pharmaceuticals Licensing & Deal Activity
Sun Pharmaceuticals is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Sun Pharmaceuticals ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Sun Pharmaceuticals include Solid Tumors (3 deals and trials), Mega Deals (2 deals and trials), and CNS Disorders (1 deal and trial). In terms of modality, Sun Pharmaceuticals has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Sun Pharmaceuticals and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Sun Pharmaceuticals's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.